Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

SELL
$145.48 - $175.02 $1,745 - $2,100
-12 Reduced 0.55%
2,188 $364,000
Q4 2022

Feb 06, 2023

BUY
$131.14 - $157.47 $524 - $629
4 Added 0.18%
2,200 $322,000
Q2 2022

Aug 08, 2022

SELL
$155.97 - $200.09 $14,349 - $18,408
-92 Reduced 4.02%
2,196 $377,000
Q1 2022

May 05, 2022

SELL
$181.39 - $234.03 $5,441 - $7,020
-30 Reduced 1.29%
2,288 $431,000
Q4 2021

Feb 24, 2022

BUY
$193.69 - $247.03 $448,973 - $572,615
2,318 New
2,318 $566,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Compass Financial Advisors LLC Portfolio

Follow Compass Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compass Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Compass Financial Advisors LLC with notifications on news.